Non-Hodgkin's Lymphoma
Showing 1 - 25 of 310
Non-hodgkin's Lymphoma Trial in Beijing (GNC-035)
Not yet recruiting
- Non-hodgkin's Lymphoma
-
Beijing, Beijing, ChinaBeijing Cancer Hospital
Sep 27, 2023
Acute Myelogenous Leukemia (AML), Acute Lymphoblastic Leukemia (ALL), Chronic Myelogenous Leukemia (CML) Trial in United States
Recruiting
- Acute Myelogenous Leukemia (AML)
- +5 more
- Conditioning Chemotherapy
- Cord blood graft
-
Basking Ridge, New Jersey
- +6 more
May 22, 2023
CNS Lymphoma, CNS Brain Cancer, Non-Hodgkin's Lymphoma Trial in Basking Ridge, Commack, New York (Rituximab, Methotrexate,
Active, not recruiting
- CNS Lymphoma
- +2 more
- Rituximab, Methotrexate, Vincristine, Procarbazine, PBPCs collection, Busulfan, Thiotepa, and Cyclophosphamide
-
Basking Ridge, New Jersey
- +2 more
Jan 27, 2023
Follicular Lymphoma, Non-Hodgkin's Lymphoma, NHL Trial run by the National Cancer Institute (NCI) (Rituximab, Copanlisib)
Recruiting
- Follicular Lymphoma
- +2 more
- Rituximab
- Copanlisib
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 25, 2023
Leukemia, Multiple Myeloma, Myelodysplastic Syndrome Trial in New York (biological, procedure, radiation, drug)
Active, not recruiting
- Leukemia
- +3 more
- Palifermin
- +6 more
-
New York, New YorkMemorial Sloan Kettering Cancer Center
Jan 23, 2023
Non-hodgkin's Lymphoma Trial in Beijing (GNC-038)
Recruiting
- Non-hodgkin's Lymphoma
-
Beijing, Beijing, ChinaBeijing Cancer Hospital
Jan 12, 2023
Non-Hodgkin's Lymphoma, Myeloma, Active Solid Malignancy Trial in New York (PET Imaging using 124 IPUH71)
Active, not recruiting
- Non-Hodgkin's Lymphoma
- +2 more
- PET Imaging using 124 IPUH71
-
New York, New YorkMemorial Sloan Kettering Cancer Center
Jan 10, 2023
Multiple Myeloma, Non-Hodgkin's Lymphoma Trial in United States (Romidepsin, Lenalidomide)
Active, not recruiting
- Multiple Myeloma
- Non-Hodgkin's Lymphoma
-
Hartford, Connecticut
- +6 more
Jan 3, 2023
Non-Hodgkin's Lymphoma, Plasma Cell Myeloma Trial in Philadelphia (procedure, drug, other)
Completed
- Non-Hodgkin's Lymphoma
- Plasma Cell Myeloma
- Hematopoietic Cell Transplantation
- +2 more
-
Philadelphia, PennsylvaniaSidney Kimmel Cancer Center at Thomas Jefferson University
Nov 16, 2022
DLBCL, Chronic Lymphocytic Leukemia, B Cell Malignancies Trial in Australia, United States (ABBV-525)
Not yet recruiting
- Diffuse Large B-Cell Lymphoma
- +3 more
-
Louisville, Kentucky
- +6 more
Nov 14, 2022
Living Conditions After Non-Hodgkin's Lymphoma in France
Not yet recruiting
- Non-hodgkin's Lymphoma
- Data collection
- Questionnaires
-
Dijon, FranceChu Dijon Bourgogne
Oct 13, 2022
Non-Hodgkin's Lymphoma Trial in Philadelphia (drug, procedure, genetic)
Completed
- Non-Hodgkin's Lymphoma
- Bendamustine
- +6 more
-
Philadelphia, PennsylvaniaSidney Kimmel Cancer Center at Thomas Jefferson University
Sep 14, 2022
Mantle Cell Lymphoma, Non-Hodgkin's Lymphoma Trial in Miami (Thalidomide)
Active, not recruiting
- Mantle Cell Lymphoma
- Non-Hodgkin's Lymphoma
-
Miami, FloridaUniversity of Miami
Sep 14, 2022
Myelodysplastic Syndrome, Hodgkin's Lymphoma, Non-Hodgkin's Lymphoma Trial in Bethesda, Minneapolis (biological, drug,
Recruiting
- Myelodysplastic Syndrome
- +4 more
- Rituximab
- +6 more
-
Bethesda, Maryland
- +1 more
Aug 20, 2022
Hodgkin's Disease, Non-Hodgkin's Lymphoma, Lymphoproliferative Disease Trial in Houston (EBV-specific T cells: A, EBV-specific T
Recruiting
- Hodgkin's Disease
- +3 more
- EBV-specific T cells: A
- EBV-specific T cells: B
-
Houston, Texas
- +1 more
Jun 28, 2022
Non-Hodgkin's Lymphoma Trial in New York (Etoposide, carboplatin, ifosfamide, Rituximab, Ifosfamide, Etoposide, Carboplatin,
Completed
- Non-Hodgkin's Lymphoma
- Etoposide, carboplatin, ifosfamide
- +2 more
-
New York, New YorkMemorial Sloan Kettering Cancer Center
May 23, 2022
ID Of Prognostic Factors In Mycosis Fungoides/Sezary Syndrome
Recruiting
- Mycosis Fungoides
- Non-Hodgkin's Lymphoma
-
Duarte, California
- +12 more
Jun 17, 2022
Relapsed/Refractory Chronic Lymphocytic Leukemia, Non-hodgkin's Lymphoma Trial (cerdulatinib)
Available
- Relapsed/Refractory Chronic Lymphocytic Leukemia
- Non-hodgkin's Lymphoma
- (no location specified)
May 6, 2022
Non-Hodgkin's Lymphoma Trial in Hangzhou (ThisCART19A)
Recruiting
- Non-Hodgkin's Lymphoma
- ThisCART19A
-
Hangzhou, Zhejiang, ChinaThe first affiliated hospital of medical college of zhejiang uni
Apr 21, 2022
Acute Lymphoblastic Leukemia, Non-Hodgkin's Lymphoma, Chronic Lymphocytic Leukemia Trial in Vancouver, Ottawa (CLIC-1901)
Recruiting
- Acute Lymphoblastic Leukemia
- +2 more
- CLIC-1901
-
Vancouver, British Columbia, Canada
- +1 more
Mar 26, 2022
Chronic Myelogenous Leukemia, Acute Myelogenous Leukemia, Myelodysplastic Syndrome Trial in Atlanta (Fludarabine, Melphalan,
Completed
- Chronic Myelogenous Leukemia
- +9 more
- Fludarabine
- +3 more
-
Atlanta, GeorgiaNorthside Hospital
Apr 4, 2022
Non-Hodgkin's Lymphoma Trial in Vitoria-Gasteiz (RiTUXimab Injection [Truxima])
Recruiting
- Non-Hodgkin's Lymphoma
- RiTUXimab Injection [Truxima]
-
Vitoria-Gasteiz, Alava, SpainHospital Universitario Araba- Sede Txagorritxu
Mar 30, 2022